(2S)-6-amino-N-[11-[4-[4-[4-[11-[[(2S)-3-hydroxy-2-[4-(3-methylsulfanylpropyl)triazol-1-yl]propanoyl]amino]undecanoyl]piperazin-1-yl]-6-[2-[2-(2-prop-2-ynoxyethoxy)ethoxy]ethylamino]-1,3,5-triazin-2-yl]piperazin-1-yl]-11-oxoundecyl]-2-[4-[(2S)-2-methylbutyl]triazol-1-yl]hexanamide

C64H111N17O8S — CID 24978572

IUPAC(2S)-6-amino-N-[11-[4-[4-[4-[11-[[(2S)-3-hydroxy-2-[4-(3-methylsulfanylpropyl)triazol-1-yl]propanoyl]amino]undecanoyl]piperazin-1-yl]-6-[2-[2-(2-prop-2-ynoxyethoxy)ethoxy]ethylamino]-1,3,5-triazin-2-yl]piperazin-1-yl]-11-oxoundecyl]-2-[4-[(2S)-2-methylbutyl]triazol-1-yl]hexanamide
SMILESC#CCOCCOCCOCCNc1nc(N2CCN(C(=O)CCCCCCCCCCNC(=O)[C@H](CO)n3cc(CCCSC)nn3)CC2)nc(N2CCN(C(=O)CCCCCCCCCCNC(=O)[C@H](CCCCN)n3cc(C[C@@H](C)CC)nn3)CC2)n1
InChIInChI=1S/C64H111N17O8S/c1-5-42-87-44-46-89-47-45-88-43-33-68-62-69-63(78-38-34-76(35-39-78)58(83)28-19-15-11-7-9-13-17-23-31-66-60(85)56(27-21-22-30-65)80-51-55(73-75-80)49-53(3)6-2)71-64(70-62)79-40-36-77(37-41-79)59(84)29-20-16-12-8-10-14-18-24-32-67-61(86)57(52-82)81-50-54(72-74-81)26-25-48-90-4/h1,50-51,53,56-57,82H,6-49,52,65H2,2-4H3,(H,66,85)(H,67,86)(H,68,69,70,71)/t53-,56-,57-/m0/s1
InChIKeySMYFYPCDLGZRIA-IEAZLBRSSA-N
MW1278.77 g/mol
LogP6.19
Rot. Bonds51

About (2S)-6-amino-N-[11-[4-[4-[4-[11-[[(2S)-3-hydroxy-2-[4-(3-methylsulfanylpropyl)triazol-1-yl]propanoyl]amino]undecanoyl]piperazin-1-yl]-6-[2-[2-(2-prop-2-ynoxyethoxy)ethoxy]ethylamino]-1,3,5-triazin-2-yl]piperazin-1-yl]-11-oxoundecyl]-2-[4-[(2S)-2-methylbutyl]triazol-1-yl]hexanamide

(2S)-6-amino-N-[11-[4-[4-[4-[11-[[(2S)-3-hydroxy-2-[4-(3-methylsulfanylpropyl)triazol-1-yl]propanoyl]amino]undecanoyl]piperazin-1-yl]-6-[2-[2-(2-prop-2-ynoxyethoxy)ethoxy]ethylamino]-1,3,5-triazin-2-yl]piperazin-1-yl]-11-oxoundecyl]-2-[4-[(2S)-2-methylbutyl]triazol-1-yl]hexanamide (PubChem CID 24978572) has the molecular formula C64H111N17O8S and a molecular weight of 1278.77 g/mol. Its IUPAC name is (2S)-6-amino-N-[11-[4-[4-[4-[11-[[(2S)-3-hydroxy-2-[4-(3-methylsulfanylpropyl)triazol-1-yl]propanoyl]amino]undecanoyl]piperazin-1-yl]-6-[2-[2-(2-prop-2-ynoxyethoxy)ethoxy]ethylamino]-1,3,5-triazin-2-yl]piperazin-1-yl]-11-oxoundecyl]-2-[4-[(2S)-2-methylbutyl]triazol-1-yl]hexanamide.

Molecular Properties

Compound Name(2S)-6-amino-N-[11-[4-[4-[4-[11-[[(2S)-3-hydroxy-2-[4-(3-methylsulfanylpropyl)triazol-1-yl]propanoyl]amino]undecanoyl]piperazin-1-yl]-6-[2-[2-(2-prop-2-ynoxyethoxy)ethoxy]ethylamino]-1,3,5-triazin-2-yl]piperazin-1-yl]-11-oxoundecyl]-2-[4-[(2S)-2-methylbutyl]triazol-1-yl]hexanamide
PubChem CID24978572
Molecular FormulaC64H111N17O8S
Molecular Weight1278.77 g/mol
Exact Mass1277.85
IUPAC Name(2S)-6-amino-N-[11-[4-[4-[4-[11-[[(2S)-3-hydroxy-2-[4-(3-methylsulfanylpropyl)triazol-1-yl]propanoyl]amino]undecanoyl]piperazin-1-yl]-6-[2-[2-(2-prop-2-ynoxyethoxy)ethoxy]ethylamino]-1,3,5-triazin-2-yl]piperazin-1-yl]-11-oxoundecyl]-2-[4-[(2S)-2-methylbutyl]triazol-1-yl]hexanamide
SMILESC#CCOCCOCCOCCNc1nc(N2CCN(C(=O)CCCCCCCCCCNC(=O)[C@H](CO)n3cc(CCCSC)nn3)CC2)nc(N2CCN(C(=O)CCCCCCCCCCNC(=O)[C@H](CCCCN)n3cc(C[C@@H](C)CC)nn3)CC2)n1
InChIInChI=1S/C64H111N17O8S/c1-5-42-87-44-46-89-47-45-88-43-33-68-62-69-63(78-38-34-76(35-39-78)58(83)28-19-15-11-7-9-13-17-23-31-66-60(85)56(27-21-22-30-65)80-51-55(73-75-80)49-53(3)6-2)71-64(70-62)79-40-36-77(37-41-79)59(84)29-20-16-12-8-10-14-18-24-32-67-61(86)57(52-82)81-50-54(72-74-81)26-25-48-90-4/h1,50-51,53,56-57,82H,6-49,52,65H2,2-4H3,(H,66,85)(H,67,86)(H,68,69,70,71)/t53-,56-,57-/m0/s1
InChIKeySMYFYPCDLGZRIA-IEAZLBRSSA-N
XLogP6.19
TPSA291.36 Ų
H-Bond Donors5
H-Bond Acceptors22
Rotatable Bonds51
Heavy Atoms90
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001278.77
LogP ≤ 56.19
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1022

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'triple_bond', 'substructure': 'N/A'}

Analyze (2S)-6-amino-N-[11-[4-[4-[4-[11-[[(2S)-3-hydroxy-2-[4-(3-methylsulfanylpropyl)triazol-1-yl]propanoyl]amino]undecanoyl]piperazin-1-yl]-6-[2-[2-(2-prop-2-ynoxyethoxy)ethoxy]ethylamino]-1,3,5-triazin-2-yl]piperazin-1-yl]-11-oxoundecyl]-2-[4-[(2S)-2-methylbutyl]triazol-1-yl]hexanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2S)-6-amino-N-[11-[4-[4-[4-[11-[[(2S)-3-hydroxy-2-[4-(3-methylsulfanylpropyl)triazol-1-yl]propanoyl]amino]undecanoyl]piperazin-1-yl]-6-[2-[2-(2-prop-2-ynoxyethoxy)ethoxy]ethylamino]-1,3,5-triazin-2-yl]piperazin-1-yl]-11-oxoundecyl]-2-[4-[(2S)-2-methylbutyl]triazol-1-yl]hexanamide?
The IUPAC name of (2S)-6-amino-N-[11-[4-[4-[4-[11-[[(2S)-3-hydroxy-2-[4-(3-methylsulfanylpropyl)triazol-1-yl]propanoyl]amino]undecanoyl]piperazin-1-yl]-6-[2-[2-(2-prop-2-ynoxyethoxy)ethoxy]ethylamino]-1,3,5-triazin-2-yl]piperazin-1-yl]-11-oxoundecyl]-2-[4-[(2S)-2-methylbutyl]triazol-1-yl]hexanamide (CID 24978572) is (2S)-6-amino-N-[11-[4-[4-[4-[11-[[(2S)-3-hydroxy-2-[4-(3-methylsulfanylpropyl)triazol-1-yl]propanoyl]amino]undecanoyl]piperazin-1-yl]-6-[2-[2-(2-prop-2-ynoxyethoxy)ethoxy]ethylamino]-1,3,5-triazin-2-yl]piperazin-1-yl]-11-oxoundecyl]-2-[4-[(2S)-2-methylbutyl]triazol-1-yl]hexanamide.
What is the SMILES notation for (2S)-6-amino-N-[11-[4-[4-[4-[11-[[(2S)-3-hydroxy-2-[4-(3-methylsulfanylpropyl)triazol-1-yl]propanoyl]amino]undecanoyl]piperazin-1-yl]-6-[2-[2-(2-prop-2-ynoxyethoxy)ethoxy]ethylamino]-1,3,5-triazin-2-yl]piperazin-1-yl]-11-oxoundecyl]-2-[4-[(2S)-2-methylbutyl]triazol-1-yl]hexanamide?
The canonical SMILES for (2S)-6-amino-N-[11-[4-[4-[4-[11-[[(2S)-3-hydroxy-2-[4-(3-methylsulfanylpropyl)triazol-1-yl]propanoyl]amino]undecanoyl]piperazin-1-yl]-6-[2-[2-(2-prop-2-ynoxyethoxy)ethoxy]ethylamino]-1,3,5-triazin-2-yl]piperazin-1-yl]-11-oxoundecyl]-2-[4-[(2S)-2-methylbutyl]triazol-1-yl]hexanamide is C#CCOCCOCCOCCNc1nc(N2CCN(C(=O)CCCCCCCCCCNC(=O)[C@H](CO)n3cc(CCCSC)nn3)CC2)nc(N2CCN(C(=O)CCCCCCCCCCNC(=O)[C@H](CCCCN)n3cc(C[C@@H](C)CC)nn3)CC2)n1.
What is the InChIKey of (2S)-6-amino-N-[11-[4-[4-[4-[11-[[(2S)-3-hydroxy-2-[4-(3-methylsulfanylpropyl)triazol-1-yl]propanoyl]amino]undecanoyl]piperazin-1-yl]-6-[2-[2-(2-prop-2-ynoxyethoxy)ethoxy]ethylamino]-1,3,5-triazin-2-yl]piperazin-1-yl]-11-oxoundecyl]-2-[4-[(2S)-2-methylbutyl]triazol-1-yl]hexanamide?
The InChIKey is SMYFYPCDLGZRIA-IEAZLBRSSA-N. The full InChI is InChI=1S/C64H111N17O8S/c1-5-42-87-44-46-89-47-45-88-43-33-68-62-69-63(78-38-34-76(35-39-78)58(83)28-19-15-11-7-9-13-17-23-31-66-60(85)56(27-21-22-30-65)80-51-55(73-75-80)49-53(3)6-2)71-64(70-62)79-40-36-77(37-41-79)59(84)29-20-16-12-8-10-14-18-24-32-67-61(86)57(52-82)81-50-54(72-74-81)26-25-48-90-4/h1,50-51,53,56-57,82H,6-49,52,65H2,2-4H3,(H,66,85)(H,67,86)(H,68,69,70,71)/t53-,56-,57-/m0/s1.
What are the key properties of (2S)-6-amino-N-[11-[4-[4-[4-[11-[[(2S)-3-hydroxy-2-[4-(3-methylsulfanylpropyl)triazol-1-yl]propanoyl]amino]undecanoyl]piperazin-1-yl]-6-[2-[2-(2-prop-2-ynoxyethoxy)ethoxy]ethylamino]-1,3,5-triazin-2-yl]piperazin-1-yl]-11-oxoundecyl]-2-[4-[(2S)-2-methylbutyl]triazol-1-yl]hexanamide?
(2S)-6-amino-N-[11-[4-[4-[4-[11-[[(2S)-3-hydroxy-2-[4-(3-methylsulfanylpropyl)triazol-1-yl]propanoyl]amino]undecanoyl]piperazin-1-yl]-6-[2-[2-(2-prop-2-ynoxyethoxy)ethoxy]ethylamino]-1,3,5-triazin-2-yl]piperazin-1-yl]-11-oxoundecyl]-2-[4-[(2S)-2-methylbutyl]triazol-1-yl]hexanamide has a molecular weight of 1278.77 g/mol, XLogP of 6.19, 51 rotatable bonds, 5 hydrogen bond donors, and 22 hydrogen bond acceptors.
Where does this data come from?
All data for (2S)-6-amino-N-[11-[4-[4-[4-[11-[[(2S)-3-hydroxy-2-[4-(3-methylsulfanylpropyl)triazol-1-yl]propanoyl]amino]undecanoyl]piperazin-1-yl]-6-[2-[2-(2-prop-2-ynoxyethoxy)ethoxy]ethylamino]-1,3,5-triazin-2-yl]piperazin-1-yl]-11-oxoundecyl]-2-[4-[(2S)-2-methylbutyl]triazol-1-yl]hexanamide is sourced from PubChem (CID 24978572), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).